Literature DB >> 21710250

Physiopathology of idiopathic nephrotic syndrome: lessons from glucocorticoids and epigenetic perspectives.

Valéry Elie1, May Fakhoury, Georges Deschênes, Evelyne Jacqz-Aigrain.   

Abstract

Idiopathic nephrotic syndrome (INS) has been studied for decades in attempt to understand the physiopathological mechanisms explaining the disease. It is recognized as a multifactorial disease, with immunological components targeting kidney functions. Many hypotheses have been discussed or tested, including the role of a circulating factor, polymorphisms of genes implicated in lymphocyte maturation and differentiation, and DNA epigenetic modifications. In the present review, the data supporting these different (and probably combinatorial) hypotheses have been reviewed in order to identify and discuss the possible pathways implicated in the physiopathology of INS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21710250     DOI: 10.1007/s00467-011-1947-1

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  68 in total

1.  Recurrence of idiopathic nephrotic syndrome after renal transplantation. 1972.

Authors: 
Journal:  J Am Soc Nephrol       Date:  2001-09       Impact factor: 10.121

Review 2.  Phenotypic plasticity and the epigenetics of human disease.

Authors:  Andrew P Feinberg
Journal:  Nature       Date:  2007-05-24       Impact factor: 49.962

3.  c-mip impairs podocyte proximal signaling and induces heavy proteinuria.

Authors:  Shao-Yu Zhang; Maud Kamal; Karine Dahan; André Pawlak; Virginie Ory; Dominique Desvaux; Vincent Audard; Marina Candelier; Fatima BenMohamed; Fatima Ben Mohamed; Marie Matignon; Christo Christov; Xavier Decrouy; Veronique Bernard; Gilles Mangiapan; Philippe Lang; Georges Guellaën; Pierre Ronco; Djillali Sahali
Journal:  Sci Signal       Date:  2010-05-18       Impact factor: 8.192

4.  The nephrotic syndrome. Its incidence and implications for the community.

Authors:  E R Schlesinger; H A Sultz; W E Mosher; J G Feldman
Journal:  Am J Dis Child       Date:  1968-12

Review 5.  The primary nephrotic syndrome of childhood. Classification and clinicopathologic study of 406 cases.

Authors:  R Habib; C Kleinknecht
Journal:  Pathol Annu       Date:  1971

6.  Rituximab efficiency in children with steroid-dependent nephrotic syndrome.

Authors:  Anne-Laure Sellier-Leclerc; Marie-Alice Macher; Chantal Loirat; Valérie Guérin; Hervé Watier; Michel Peuchmaur; Véronique Baudouin; Georges Deschênes
Journal:  Pediatr Nephrol       Date:  2010-03-18       Impact factor: 3.714

Review 7.  Genetic forms of nephrotic syndrome.

Authors:  Patrick Niaudet
Journal:  Pediatr Nephrol       Date:  2004-12       Impact factor: 3.714

8.  Glucocorticoids protect and enhance recovery of cultured murine podocytes via actin filament stabilization.

Authors:  Richard F Ransom; Nancy G Lam; Mark A Hallett; Simon J Atkinson; William E Smoyer
Journal:  Kidney Int       Date:  2005-12       Impact factor: 10.612

9.  A humanized mouse model of idiopathic nephrotic syndrome suggests a pathogenic role for immature cells.

Authors:  Anne-Laure Sellier-Leclerc; Arnaud Duval; Stéphanie Riveron; Marie-Alice Macher; Georges Deschenes; Chantal Loirat; Marie-Christine Verpont; Michel Peuchmaur; Pierre Ronco; Renato C Monteiro; Elie Haddad
Journal:  J Am Soc Nephrol       Date:  2007-09-12       Impact factor: 10.121

10.  A novel immunodeficiency associated with hypomorphic RAG1 mutations and CMV infection.

Authors:  Jean-Pierre de Villartay; Annick Lim; Hamoud Al-Mousa; Sophie Dupont; Julie Déchanet-Merville; Edith Coumau-Gatbois; Marie-Lise Gougeon; Arnaud Lemainque; Céline Eidenschenk; Emmanuelle Jouanguy; Laurent Abel; Jean-Laurent Casanova; Alain Fischer; Françoise Le Deist
Journal:  J Clin Invest       Date:  2005-11       Impact factor: 14.808

View more
  25 in total

1.  Dosing of glucocorticosteroids in nephrotic syndrome.

Authors:  Otto Mehls; Peter F Hoyer
Journal:  Pediatr Nephrol       Date:  2011-09-09       Impact factor: 3.714

2.  Urine and serum ghrelin, sCD80 and sCTLA-4 levels in doxorubicin-induced experimental nephrotic syndrome.

Authors:  Duygu Ozkorucu; Nuran Cetin; Nadide Melike Sav; Bilal Yildiz
Journal:  Int Urol Nephrol       Date:  2016-02-27       Impact factor: 2.370

3.  Low expression of glucocorticoid receptors in children with steroid-resistant nephrotic syndrome.

Authors:  Ayman Hammad; Sohier Yahia; Mona Samy Gouida; Ashraf Bakr; Reham M El-farahaty
Journal:  Pediatr Nephrol       Date:  2013-01-09       Impact factor: 3.714

4.  Role of the glucocorticoid receptor in the recurrence of primary nephrotic syndrome.

Authors:  Yumei Liang; Yinyin Chen; Ying Chen; Yuting Gong
Journal:  Exp Ther Med       Date:  2015-07-30       Impact factor: 2.447

5.  Recurrent lymphadenopathy in children with Kikuchi-Fujimoto disease.

Authors:  In Hyuk Yoo; Hyunju Na; E Young Bae; Seung Beom Han; Soo Young Lee; Dae Chul Jeong; Jin Han Kang
Journal:  Eur J Pediatr       Date:  2014-04-09       Impact factor: 3.183

6.  Rituximab in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome.

Authors:  Piero Ruggenenti; Barbara Ruggiero; Paolo Cravedi; Marina Vivarelli; Laura Massella; Maddalena Marasà; Antonietta Chianca; Nadia Rubis; Bogdan Ene-Iordache; Michael Rudnicki; Rosa Maria Pollastro; Giovambattista Capasso; Antonio Pisani; Marco Pennesi; Francesco Emma; Giuseppe Remuzzi
Journal:  J Am Soc Nephrol       Date:  2014-01-30       Impact factor: 10.121

7.  Transethnic, Genome-Wide Analysis Reveals Immune-Related Risk Alleles and Phenotypic Correlates in Pediatric Steroid-Sensitive Nephrotic Syndrome.

Authors:  Hanna Debiec; Claire Dossier; Eric Letouzé; Christopher E Gillies; Marina Vivarelli; Rosemary K Putler; Elisabet Ars; Evelyne Jacqz-Aigrain; Valery Elie; Manuela Colucci; Stéphanie Debette; Philippe Amouyel; Siham C Elalaoui; Abdelaziz Sefiani; Valérie Dubois; Tabassome Simon; Matthias Kretzler; Jose Ballarin; Francesco Emma; Matthew G Sampson; Georges Deschênes; Pierre Ronco
Journal:  J Am Soc Nephrol       Date:  2018-06-14       Impact factor: 10.121

Review 8.  Minimal Change Disease.

Authors:  Marina Vivarelli; Laura Massella; Barbara Ruggiero; Francesco Emma
Journal:  Clin J Am Soc Nephrol       Date:  2016-12-09       Impact factor: 8.237

9.  Ofatumumab in two pediatric nephrotic syndrome patients allergic to rituximab.

Authors:  Marina Vivarelli; Manuela Colucci; Alice Bonanni; Martina Verzani; Jessica Serafinelli; Francesco Emma; Gianmarco Ghiggeri
Journal:  Pediatr Nephrol       Date:  2016-09-29       Impact factor: 3.714

Review 10.  Idiopathic nephrotic syndrome: the EBV hypothesis.

Authors:  Claire Dossier; Agnès Jamin; Georges Deschênes
Journal:  Pediatr Res       Date:  2016-09-28       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.